UNSPSC 51401561: Chlordiazepoxide hydrochloride

This classification denotes a benzodiazepine with the molecular formula C16H14ClN3O.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MFM6K1XWDK, chemically known as 7-chloro-n-methyl-5-phenyl-3h-1,4-benzodiazepin-2-amine 4-oxide but more generally known as chlordiazepoxide hydrochloride, which bears US NIH Compound Identifier 2712. European Medicines Agency schedules Chlordiazepoxide hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01213MIG.

UNSPSC 51401561 Chlordiazepoxide hydrochloride is a Commodity code that represents a specific benzodiazepine pharmaceutical used for anxiety and sedation management. The recent state and local procurement activity under this code does not reflect actual purchases of chlordiazepoxide; instead, the only recent solicitation shows a clear mismatch between the code assignment and the work being bought. Seminole County, Florida posted an IFB (Invitation for Bid) in June 2026 to procure naloxone and drug deactivation systems — opioid-overdose reversal agents and harm-reduction equipment entirely unrelated to the code's nominal scope of chlordiazepoxide hydrochloride. The code shows minimal relevant recent activity; the single opportunity tagged under it appears to reflect a coding error or system artifact rather than genuine procurement demand for the pharmaceutical.

Issuing bodies accessing this code appear limited to county-level health departments and public health authorities, though the single recent record provides insufficient evidence of a sustained buyer base or repeat procurement pattern. The geographic spread is currently limited to Florida based on available records. Given the absence of authentic chlordiazepoxide procurement signals and the presence of only one misaligned opportunity, practitioners should treat this code as inactive for business development purposes and monitor for corrected records or future solicitations that align the code assignment with pharmaceutical products actually being purchased by state and local agencies.